Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment
- PMID: 16508438
- DOI: 10.1097/00006982-200603000-00016
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical